Literature DB >> 25282566

Distinct behavior of human Langerhans cells and inflammatory dendritic epidermal cells at tight junctions in patients with atopic dermatitis.

Kazue Yoshida1, Akiharu Kubo2, Harumi Fujita3, Mariko Yokouchi4, Ken Ishii5, Hiroshi Kawasaki4, Toshifumi Nomura6, Hiroshi Shimizu6, Keisuke Kouyama7, Tamotsu Ebihara4, Keisuke Nagao4, Masayuki Amagai8.   

Abstract

BACKGROUND: The stratum corneum and tight junctions (TJs) form physical barriers in the epidermis. Dendrites of activated Langerhans cells (LCs) extend beyond the TJs to capture external antigens in mice. LCs and inflammatory dendritic epidermal cells (IDECs) are observed in the skin of patients with atopic dermatitis (AD).
OBJECTIVE: We sought to investigate the characteristics of LCs and IDECs and the distribution of their antigen capture receptors in relation to TJs in normal and AD skin.
METHODS: We characterized the interactions of LCs and IDECs with TJs and the expression patterns of langerin and FcεRI by using whole-mount epidermal sheets from healthy subjects and patients with AD, ichthyosis vulgaris, and psoriasis vulgaris.
RESULTS: As in mouse skin, activated LCs penetrate TJs in human skin. The number of LCs with TJ penetration increased approximately 5-fold in erythematous lesional skin of patients with AD but not in nonlesional skin of patients with AD or lesions of patients with ichthyosis vulgaris or psoriasis. In contrast, IDECs localized in the lower part of the epidermis, and their dendrites extended horizontally without penetration through TJs. Although langerin accumulated on the tips of dendrites of activated LCs, FcεRI was expressed diffusely on the cell surfaces on LCs and IDECs in lesional skin from patients with AD.
CONCLUSIONS: These findings highlight interesting differences between LCs and IDECs in epidermis of patients with AD, where LCs, but not IDECs, extend dendrites through the TJs, likely to capture antigens from outside the TJ barrier with a polarized distribution of langerin but not FcεRI. These behavioral differences between skin dendritic cells might reflect an important pathophysiology of AD.
Copyright © 2014 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FcεRI; Langerhans cell; atopic dermatitis; inflammatory dendritic epidermal cell; langerin; stratum corneum; tight junction

Mesh:

Substances:

Year:  2014        PMID: 25282566     DOI: 10.1016/j.jaci.2014.08.001

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  36 in total

Review 1.  Duality at the gate: Skin dendritic cells as mediators of vaccine immunity and tolerance.

Authors:  Christopher J Nirschl; Niroshana Anandasabapathy
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

Review 2.  The Skin as a Route of Allergen Exposure: Part II. Allergens and Role of the Microbiome and Environmental Exposures.

Authors:  George Knaysi; Anna R Smith; Jeffrey M Wilson; Julia A Wisniewski
Journal:  Curr Allergy Asthma Rep       Date:  2017-01       Impact factor: 4.806

3.  EpCAM Expressed by Murine Epidermal Langerhans Cells Modulates Immunization to an Epicutaneously Applied Protein Antigen.

Authors:  Takeshi Ouchi; Gaku Nakato; Mark C Udey
Journal:  J Invest Dermatol       Date:  2016-04-19       Impact factor: 8.551

Review 4.  Tight junctions in skin inflammation.

Authors:  Katja Bäsler; Johanna M Brandner
Journal:  Pflugers Arch       Date:  2016-11-16       Impact factor: 3.657

Review 5.  The Skin as a Route of Allergen Exposure: Part I. Immune Components and Mechanisms.

Authors:  Anna R Smith; George Knaysi; Jeffrey M Wilson; Julia A Wisniewski
Journal:  Curr Allergy Asthma Rep       Date:  2017-01       Impact factor: 4.806

Review 6.  Metal nanomaterials: Immune effects and implications of physicochemical properties on sensitization, elicitation, and exacerbation of allergic disease.

Authors:  Katherine A Roach; Aleksandr B Stefaniak; Jenny R Roberts
Journal:  J Immunotoxicol       Date:  2019-12       Impact factor: 3.000

7.  Report from the National Institute of Allergy and Infectious Diseases workshop on "Atopic dermatitis and the atopic march: Mechanisms and interventions".

Authors:  Wendy F Davidson; Donald Y M Leung; Lisa A Beck; Cecilia M Berin; Mark Boguniewicz; William W Busse; Talal A Chatila; Raif S Geha; James E Gern; Emma Guttman-Yassky; Alan D Irvine; Brian S Kim; Heidi H Kong; Gideon Lack; Kari C Nadeau; Julie Schwaninger; Angela Simpson; Eric L Simpson; Jonathan M Spergel; Alkis Togias; Ulrich Wahn; Robert A Wood; Judith A Woodfolk; Steven F Ziegler; Marshall Plaut
Journal:  J Allergy Clin Immunol       Date:  2019-01-09       Impact factor: 10.793

Review 8.  Epithelial barrier repair and prevention of allergy.

Authors:  Elena Goleva; Evgeny Berdyshev; Donald Ym Leung
Journal:  J Clin Invest       Date:  2019-02-18       Impact factor: 14.808

9.  Minimally invasive skin tape strip RNA sequencing identifies novel characteristics of the type 2-high atopic dermatitis disease endotype.

Authors:  Nathan Dyjack; Elena Goleva; Cydney Rios; Byung Eui Kim; Lianghua Bin; Patricia Taylor; Caroline Bronchick; Clifton F Hall; Brittany N Richers; Max A Seibold; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2018-01-06       Impact factor: 10.793

10.  Staphylococcus aureus Exploits Epidermal Barrier Defects in Atopic Dermatitis to Trigger Cytokine Expression.

Authors:  Teruaki Nakatsuji; Tiffany H Chen; Aimee M Two; Kimberly A Chun; Saisindhu Narala; Raif S Geha; Tissa R Hata; Richard L Gallo
Journal:  J Invest Dermatol       Date:  2016-07-02       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.